Chevron Left
Back to Drug Commercialization

Learner Reviews & Feedback for Drug Commercialization by University of California San Diego

4.7
stars
1,206 ratings

About the Course

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environ­ment using a much larger group of patients. This enables new treat­ment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall develop­ment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Top reviews

JR

Jan 7, 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.

AZ

Nov 9, 2020

Excellent content and lecturers. Great course to finish this specialization. I strongly recommend the three courses for those interested in pursuing a career in pharma or willing to shift.

Filter by:

201 - 223 of 223 Reviews for Drug Commercialization

By Alena T

Jun 21, 2020

very interesting!

By Vikash K

Sep 10, 2023

Usefull Course

By Qier W

Jul 11, 2020

Great course!

By Gabriel R

Sep 22, 2021

GREAT !

By Amirah a J

Oct 19, 2022

-()

By Sewati P

Sep 7, 2022

Good

By Mohamed T H

Jul 24, 2020

Much better than the Drug Discovery and Drug Development courses in this specialization. In particular, the 2nd half of 3rd week was understandable and clearly taught. That part I think was later added and was not a part of the lectures otherwise used in these courses. That section really showed the potential of these courses which unfortunately was not reached due to the lectures that were used. Most of the time the presentation slides were filled with so many texts that you would wonder if its a presentation or an article. This course was better than the previous two courses though. After completing the three courses I feel that these courses could be much better if the course providers would improve the presentations used. Nonetheless, the course was informative. But there's only so much that one can absorb with so busy slides with not so attractive layout.

By Zhuohong X

Jan 10, 2024

This review is for the Drug Discovery, Development, and Commercialization. The pluses are that industrial people came to talk about the real scenarios and trends they have seen. The big negative here is that these recordings were super outdated. They were recorded around 2013 (some are around 2016). Ten years in pharma is a long time. They should have updated these courses because of all the advancement in gene therapies, biologics, biosimilars, etc. Another negative is this is a one-way teaching. It is lacking in interaction. The discussion forum is not monitored and the post volume is very low (~30). This course does spark more interests from me. Now I have understood the pharma industry in 2013, I want to get more up-to-date understanding, just like I have read the beginning of the story and look forward to hearing more about how it goes.

By Dauletbekov

Jan 2, 2020

The course is exremely useful and packs a lot of knowledge, however it's regrettable that the course was made in 2013-2014, and since then it was not updated. The pauses at the beginning of videos make you unsure whether you hit the right button, so I think that videos could be better edited. I found that lectures with Remi Brouard were not focussed and sometimes repetitive with what Dr Ettouti said already on industry collaboration. Overall, I found the course extremely useful, providing lot of insightful knowledge.

By Kierstin L

Aug 23, 2017

Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.

By Danna F M

Sep 29, 2019

The course was very interesting and cover differents topics to give me an overview of drug commercialization in USA. In addition, the experiences shared from the each professor was excelent. However, I didn't know that the majority of topics were made in 2013. So this information was missing when I applied for this course.

By George L

Mar 7, 2021

I found this course to be very engaging and informative about the Drug Development Process. However, most of the information is outdated - the course was recorded in 2015 and a lot has changed in pharma since then. I would give it a 5-stare rating if I had taken the course say 4-5 years ago.

By Dei M M L

Dec 26, 2021

It is an excellent course from Coursera for learning on strategies for drug commercialization including pharmacoeconomics and how pharmaceuticals partners with other stakeholders to accomplish this.

By Alexander B

Nov 2, 2020

Most of materials are quite outdated and also quality of presentations sometimes was not that good.

By Richik N M

Jul 19, 2020

Not enough materials on HEOR and Phase IV studies. Week 4's lectures were redundant.

By Saudamini R

Jun 8, 2020

Its a wonderful course, but i would request the faculty to include more recent data

By m_taisir k

Oct 24, 2017

some lectures are not understand

but generally

thank you

By vincent l

Feb 19, 2018

It was alright, couldve given more examples and cases

By yousef e

Sep 29, 2019

i think part one in week 4 is too bad

By Deleted A

Jun 2, 2019

Audio ruim

By Nisha k

Nov 3, 2022

good

By Manuel M

Sep 14, 2022

Outdated series of classes that offer no real learning opportunities.

By Se a

Jan 1, 2023

The course needs to be updated with much newer lectures.

The sound quality in a lot of the lectures was quite bad.